Liminal BioSciences Inc.
10:30 AM - 10:45 AM (EST), Tuesday, February 7, 2023 ・ Winter Garden
Liminal BioSciences is a development-stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic and metabolic diseases using our drug discovery platform with a data-driven approach. Liminal BioSciences has its registered office in Bellevlle, Ontario and talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market (LMNL).
Ticker:
LMNL
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Quebec
Company HQ Country:
Canada
Year Founded:
Not Provided
Main Therapeutic Focus:
Inflammation
Lead Product in Development:
GPR84 Antagonist
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
